Keyphrases
Antimicrobial Therapy
50%
Assessment Approach
25%
Assessment Development
25%
Bacillus Isolates
25%
Carbapenem Resistance
25%
Carbapenem-resistant Acinetobacter Baumannii
25%
Chinese Experience
25%
Clinical Infectious Diseases
25%
Clinical Issues
25%
Clinical Microbiology
25%
Clinical Pharmacology
25%
Clinical Practice Guidelines
25%
Control Method
25%
Current Clinical Practice
25%
Development Approach
25%
Diagnosis Treatment
100%
Enterobacteria
25%
Evaluation Approach
25%
Evaluation Assessment
25%
Evidence Profile
25%
Expert Opinion
25%
Extensively Drug-resistant
25%
Global Public Health
25%
Grading of Recommendations
25%
Gram-negative Bacilli
100%
Group Covering
25%
Guideline Development Group
25%
Guideline Methodology
25%
Guideline-based
25%
High Mortality
25%
Infection Control
100%
Infection Diagnosis
100%
Infection Prevention
100%
Infection Treatment
100%
Infectious Diseases
25%
Laboratory Testing
25%
Multidisciplinary Guideline
25%
Multidrug-resistant Pseudomonas Aeruginosa (MDRPA)
25%
Pandrug-resistant
25%
Population Interventions
25%
Population Outcomes
25%
Public Health Risk
25%
Randomized Controlled Trial
50%
Recommendation Approach
25%
Relevant Evidence
25%
Risk Profile
25%
Strength of Recommendations
25%
Treatment Options
25%
Treatment-related
25%
Medicine and Dentistry
Acinetobacter Baumannii
14%
Antimicrobial Therapy
28%
Carbapenem
100%
Clinician
14%
Enterobacteriales
14%
Epileptic Absence
14%
Gram-Negative Bacteria
100%
Infection
100%
Infection Control
14%
Laboratory Test
14%
Observational Study
14%
Pseudomonas aeruginosa
14%
Public Health
14%
Randomized Controlled Trial
28%
Systematic Review
14%
Pharmacology, Toxicology and Pharmaceutical Science
Acinetobacter Baumannii
14%
Antiinfective Agent
14%
Antimicrobial Therapy
14%
Carbapenem
100%
Clinical Pharmacology
14%
Enterobacteriales
14%
Epileptic Absence
14%
Gram Negative Bacterium
100%
Infection
100%
Observational Study
14%
Pseudomonas aeruginosa
14%
Randomized Controlled Trial
28%